Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 15 de 15
Filtrer
1.
Nano Lett ; 17(1): 186-193, 2017 01 11.
Article de Anglais | MEDLINE | ID: mdl-28073272

RÉSUMÉ

Future multifunctional hybrid devices might combine switchable molecules and 2D material-based devices. Spin-crossover compounds are of particular interest in this context since they exhibit bistability and memory effects at room temperature while responding to numerous external stimuli. Atomically thin 2D materials such as graphene attract a lot of attention for their fascinating electrical, optical, and mechanical properties, but also for their reliability for room-temperature operations. Here, we demonstrate that thermally induced spin-state switching of spin-crossover nanoparticle thin films can be monitored through the electrical transport properties of graphene lying underneath the films. Model calculations indicate that the charge carrier scattering mechanism in graphene is sensitive to the spin-state dependence of the relative dielectric constants of the spin-crossover nanoparticles. This graphene sensor approach can be applied to a wide class of (molecular) systems with tunable electronic polarizabilities.

2.
Langmuir ; 30(30): 9028-35, 2014 Aug 05.
Article de Anglais | MEDLINE | ID: mdl-25000178

RÉSUMÉ

In this work, we report on the self-assembly of bimetallic CoFe carbide magnetic nanoparticles (MNPs) stabilized by a mixture of long chain surfactants. A dedicated setup, coupling dip coating and sputtering chamber, enables control of the self-assembly of MNPs from regular stripe to continuous thin films under inert atmosphere. The effects of experimental parameters, MNP concentration, withdrawal speed, amount, and nature of surfactants, as well as the surface state of the substrates are discussed. Magnetic measurements revealed that the assembled particles were not oxidized, confirming the high potentiality of our approach for the controlled deposition of highly sensitive MNPs.

3.
J Chromatogr A ; 995(1-2): 87-97, 2003 May 02.
Article de Anglais | MEDLINE | ID: mdl-12800925

RÉSUMÉ

There is a need for a better characterization of sludges from wastewater treatment plants which are destined to be spread on agricultural lands. Inorganic pollutants are regularly controlled but organic pollutants have received few attention up to now. On this paper, we have been interested on the analysis of the 16 polycyclic aromatic hydrocarbons (PAHs) listed in the US Environmental Protection Agency (US EPA) priority list and more particularly of the six PAHs listed in the European community list (fluoranthene, benzo[b and k]fluoranthene, benzo[a]pyrene, benzo[ghi]perylene, indeno[1,2,3-cd]pyrene). The analysis step consists on liquid chromatography with both fluorescence and UV detections as described in the EPA Method 8310. As for the extraction step, several techniques such as supercritical fluid extraction, pressurized liquid extraction, focused microwave extraction in open vessels, Soxhlet and ultrasonic extractions are compared after optimization of the experimental conditions (solvent nature and quantity, temperature, pressure, duration, ... ) and validation with certified sludges. When optimized, these five extraction techniques are as much efficient with similar relative standard deviation. Whatever the extraction techniques used, the whole analysis protocol permits to quantify PAHs in the range of 0.09 to 0.9 mg/kg of dried sludges.


Sujet(s)
Chromatographie en phase liquide à haute performance/méthodes , Composés polycycliques/analyse , Eaux d'égout/composition chimique , Spectrométrie de fluorescence/méthodes , Spectrophotométrie UV/méthodes , Normes de référence
4.
Leuk Lymphoma ; 40(5-6): 529-40, 2001 Feb.
Article de Anglais | MEDLINE | ID: mdl-11426526

RÉSUMÉ

This prospective study was undertaken to evaluate the efficacy and toxicity of combination chemotherapy with alternating cycles of vincristine, doxorubicin and dexamethasone (VAD) and cyclophophamide, doxorubicin, etoposide and prednisone (CHEP) in patients over 60 years old with previously untreated and advanced non-Hodgkin's lymphoma (NHL) of intermediate- and high-grade malignancy. Eighty one consecutive, patients with NHL referred from April 1992 to October 1997 to GOELAMS centers were enrolled in this study and their outcome updated to June 1, 1999. Of 81 enrolled patients, 77 were eligible and assessable for response. The median age was 70 years (61 to 78), 85.7% were stage III or IV, 39% were of performance status > or = 2, 27.3% > or = 2 involved extra-nodal sites and 57.3% had higher LDH levels than normal. The immunophenotype was B in 87% and T in 13%. Fifty-one (66.2%) patients received the scheduled eight cycles of therapy and treatment was withdrawn in only 6 patients (7.8%) because of toxicity. Neutropenia grade 3-4 occurred in 11.1% after VAD courses vs 40.6% after CHEP courses. The mean cumulative dose of doxorubicin was 269 mg/m2 and the relative dose intensity was 84%. The overall response and complete response rates were 66.2% and 51.9% respectively, and after a median follow-up of 52 months the 3 year overall survival (OS) and event-free survival rates (EFS) were 43.5% and 33.0% respectively. In multivariate analysis, OS and EFS were statistically influenced by IPI (p = 3 x 10(-3); p < 1 x 10(-4)) and phenotype (p = 2 x 10(-3); p < 1 x 10(-4)). Our findings support the alternation of 4 courses of VAD and CHEP as it is well tolerated in patients over 60 years old with advanced intermediate- or high-grade NHL and provides response and survival rates comparable to 6 courses of CHOP.


Sujet(s)
Protocoles de polychimiothérapie antinéoplasique/administration et posologie , Lymphome malin non hodgkinien/traitement médicamenteux , Sujet âgé , Protocoles de polychimiothérapie antinéoplasique/effets indésirables , Cyclophosphamide/administration et posologie , Cyclophosphamide/effets indésirables , Dexaméthasone/administration et posologie , Dexaméthasone/effets indésirables , Doxorubicine/administration et posologie , Doxorubicine/effets indésirables , Étoposide/administration et posologie , Étoposide/effets indésirables , Femelle , Humains , Perfusions veineuses , Lymphome malin non hodgkinien/mortalité , Lymphome malin non hodgkinien/anatomopathologie , Mâle , Adulte d'âge moyen , Prednisone/administration et posologie , Prednisone/effets indésirables , Études prospectives , Analyse de survie , Vincristine/administration et posologie , Vincristine/effets indésirables
5.
Presse Med ; 30(4): 163-5, 2001 Feb 03.
Article de Français | MEDLINE | ID: mdl-11229304

RÉSUMÉ

BACKGROUND: Extranodal involvement is not unusual in mantle cell lymphoma (MCL) which accounts for 6% of non-Hodgkin's lymphomas. Simultaneous localization in the eyelid and in the breast, as observed in our case, is however exceptional. CASE REPORT: Chronic lymphoid leukemia (CLL) was suspected in a 71-year-old woman with asthenia, a cervical and axillary nodal enlargement and elevated lymphocyte count. Blood immunoflow cytometry analysis, occurrence of rapidly growing tumors involving the two breasts and eyelids and cytogenetic and molecular features led to the diagnosis of MCL. A very good partial remission was obtained with second-line polychemotherapy composed of cytarabin, cisplatin and dexamethasone, but lasted only 3 months after the end of 6 cycles. DISCUSSION: Primary breast and eyelid lymphomas are rare. Such localizations are exceptional in MCL and are signs of aggressive disease. Before extra-nodal involvement, MCL may simulate banal CLL. Therefore, systematic immunohistochemistry and if necessary molecular analysis are useful for early diagnosis of MCL. Prognosis is particularly poor. Conventional chemotherapy cannot provide cure of MCL and median survival is 48 months. For this reason, high-dose chemotherapy with stem cell graft has to be discussed in young patients. MCL is currently characterized by Bcl1 rearrangement, t(11-14) translocation and cyclin D1 overexpression among small B-cell lymphomas in recent REAL- and WHO-classifications.


Sujet(s)
Tumeurs du sein/anatomopathologie , Tumeurs de la paupière/anatomopathologie , Lymphome à cellules du manteau/anatomopathologie , Sujet âgé , Protocoles de polychimiothérapie antinéoplasique/usage thérapeutique , Tumeurs du sein/diagnostic , Tumeurs du sein/thérapie , Association thérapeutique , Tumeurs de la paupière/diagnostic , Tumeurs de la paupière/thérapie , Femelle , Transplantation de cellules souches hématopoïétiques , Humains , Immunohistochimie , Lymphome à cellules du manteau/diagnostic , Lymphome à cellules du manteau/thérapie , Pronostic
6.
Eur J Haematol ; 66(1): 11-7, 2001 Jan.
Article de Anglais | MEDLINE | ID: mdl-11168502

RÉSUMÉ

Few studies have been performed regarding multiple myeloma (MM) in elderly patients. We report a retrospective series of 130 unselected patients with MM aged 75 yr or more at diagnosis. Presenting features were identical to those reported in younger patients, except for a higher rate of infection. Heavy comorbidity was characteristic of unselected geriatric patients. Ninety-four patients received conventional chemotherapy. The response rate was 62%. Treatment toxicity was mild. Median survival was 22 months. Durie-Salmon (DS) clinical stages II and III MM were severe and often led to death, while significantly more patients with DS stage I MM died from unrelated causes (p<0.0001). Univariate analysis showed that age > or = 85 yr, performance status > or = 2, creatinine level > or = 120 micromol/l, beta 2 microglobulin level > 4 mg/l, C-reactive protein level > 6 mg/l, platelet count < 100 x 10(9)/l, presence of infection and lack of response to chemotherapy were adverse prognostic factors for survival. In Cox multivariate regression analysis, age > or = 85 yr (p<0.0001), performance status > or = 2 (p<0.0001) and creatinine level > or = 120 micromol/l (p<0.0001) were independent factors in predicting short survival. This study provides evidence that in patients with symptomatic MM age should not be considered as a major obstacle to active treatment. Prospective clinical trials are needed in this population of patients and should include an assessment of quality of life.


Sujet(s)
Myélome multiple/épidémiologie , Sujet âgé , Sujet âgé de 80 ans ou plus , Protocoles de polychimiothérapie antinéoplasique/administration et posologie , Protocoles de polychimiothérapie antinéoplasique/usage thérapeutique , Cause de décès , Comorbidité , Cyclophosphamide/administration et posologie , Dexaméthasone/administration et posologie , Doxorubicine/administration et posologie , Étoposide/administration et posologie , Femelle , France/épidémiologie , Humains , Interféron alpha/administration et posologie , Tables de survie , Lomustine/administration et posologie , Mâle , Melphalan/administration et posologie , Myélome multiple/sang , Myélome multiple/diagnostic , Myélome multiple/traitement médicamenteux , Myélome multiple/anatomopathologie , Protéines de myélome/analyse , Stadification tumorale , Syndromes paranéoplasiques/épidémiologie , Prednimustine/administration et posologie , Prednisone/administration et posologie , Pronostic , Modèles des risques proportionnels , Études rétrospectives , Analyse de survie , Résultat thérapeutique , Vincristine/administration et posologie
7.
J Chromatogr A ; 859(1): 29-39, 1999 Oct 22.
Article de Anglais | MEDLINE | ID: mdl-10563413

RÉSUMÉ

A selective clean-up procedure using immunoaffinity solid-phase extraction was applied for the trace-level determination of polycyclic aromatic hydrocarbons (PAHs) in urban waste water and sewage sludges used for soil amendment. Anti-pyrene antibodies have been immobilized on a silica-based sorbent and the cross-reactivity of the antibodies towards structurally related compounds were allowed to extract the whole class of priority PAHs. The selectivity of the antibodies provided clean extracts from sludges and, therefore, the identification and quantification were shown to be easier using either liquid chromatography (LC) with UV diode array and fluorescence detection in series or gas chromatography-mass spectrometry (GC-MS), although some loss of up to 50% was observed for the clean-up. The identification of the PAHs by matching of UV and MS spectra was greatly improved. The procedure, including immunoclean-up and LC coupled to diode array and fluorescence detection, was validated using certified reference materials with native PAHs of concentrations in the range of 0.57-2.16 mg/kg (dry sludges).


Sujet(s)
Chromatographie en phase gazeuse/méthodes , Chromatographie en phase liquide/méthodes , Composés polycycliques/analyse , Eaux d'égout/composition chimique , Polluants chimiques de l'eau/analyse , Surveillance de l'environnement/méthodes , Reproductibilité des résultats , Spectrométrie de fluorescence , Spectrophotométrie UV
8.
Presse Med ; 28(6): 277-8, 1999 Feb 13.
Article de Français | MEDLINE | ID: mdl-10073168

RÉSUMÉ

BACKGROUND: Coeliac disease is known to favor the development of neoplasia. Coeliac disease associated with small-cell carcinoma of the esophagus has not been reported to date. CASE REPORT: A 51-year-old man with coeliac disease known for several years was hospitalized for epigastric pain. Work-up led to the diagnosis of small-cell carcinoma of the lower esophagus. The patient was treated with 6 cycles of chemotherapy using an etoposide-ciplatinum protocol associated with 60 Gy radiotherapy starting at the third cycle. The patient has remained in complete remission 2 years after diagnosis. DISCUSSION: Small-cell carcinoma of the esophagus is an exceptional finding in a patient with coeliac disease. Chemotherapy associated with radiotherapy has been successful in our patient.


Sujet(s)
Carcinome à petites cellules/étiologie , Maladie coeliaque/complications , Tumeurs de l'oesophage/étiologie , Protocoles de polychimiothérapie antinéoplasique , Carcinome à petites cellules/traitement médicamenteux , Carcinome à petites cellules/radiothérapie , Cisplatine/usage thérapeutique , Protocoles cliniques , Tumeurs de l'oesophage/traitement médicamenteux , Tumeurs de l'oesophage/radiothérapie , Étoposide/usage thérapeutique , Humains , Mâle , Adulte d'âge moyen , Induction de rémission
9.
J Chromatogr A ; 823(1-2): 219-30, 1998 Oct 09.
Article de Anglais | MEDLINE | ID: mdl-9818404

RÉSUMÉ

There is a need for a better characterization of sludges from wastewater treatment plants which are destined to be spread on agricultural land. Inorganic pollutants are regularly controlled, but organic pollutants have received little attention up to now. The main problem for trace analysis of organic pollutants comes from the complexity of the various matrices of sludges, which depends on their origins. Therefore, methods described for soils and sediments cannot be directly applied to sludges which contain high amount of lipids. This paper provides a method for trace-determination of polycyclic aromatic hydrocarbons in the range of mg/kg of dried sludge including an extraction step, and an analysis step by liquid chromatography with fluorescence detection for sensitive quantification and UV-diode-array detection for confirmation. The extraction step was optimized by a selection of the solvent used for both Soxhlet and supercritical-fluid extraction and by setting the experimental conditions (temperature, pressure, modifier, etc.) used for SFE. Extraction recoveries were found similar and quantitative for the two procedures. However supercritical-fluid extraction appears to be a good alternative to Soxhlet extraction because of the consumption of less time and solvent. Detection limits were obtained in the range of 0.1-1 mg/kg of dried sludges, with possible confirmation by UV spectra. The whole method (extraction/quantification/confirmation) was validated using sludges which have been certified by the Community Bureau of Reference from Brussels (CRM No. 088). Application to the determination of PAHs in urban sludges is presented.


Sujet(s)
Chromatographie en phase liquide/méthodes , Hydrocarbures aromatiques polycycliques/analyse , Eaux d'égout/composition chimique , Solvants , Cyclohexanes , Dichloro-méthane , Spectrométrie de fluorescence , Spectrophotométrie UV , Toluène
10.
J Chromatogr A ; 795(1): 27-42, 1998 Jan 30.
Article de Anglais | MEDLINE | ID: mdl-9503634

RÉSUMÉ

The parameters governing solid-phase microextraction (SPME) are investigated, with emphasis on the determination of the partition coefficients, K, and their use to predict the selection of a fibre, depending on the respective characteristics of the fibres and the analytes. Film thickness and stability of the compounds can interfere with the determination of K values. The time profile curves were determined for twelve pesticides having a wide range of water solubilities and polarities and using four fibres (polydimethylsiloxane, polydimethylsiloxane-divinylbenzene, Carbowax-divinylbenzene and polyacrylate). Although the affinity order was different for the four coatings, no correlation was found between the respective characteristics of the fibres and solutes. The two fibres containing divinylbenzene were shown to have the highest affinities and the polydimethylsiloxane had the lowest affinity. The polyacrylate fibre which is the more polar commercial fibre did not provide the highest affinities for the more polar and water-soluble analytes. The important parameters for quantitative analysis have been evaluated. The calibration curves were similar when one analyte of interest was present on its own in a drinking water sample, or when eleven other pesticides were present at the same concentration or when much higher concentrations of other analytes were present in the sample. Linearity was obtained over a wide range of concentrations in drinking water samples. Detection limits are in agreement with European regulatory levels in drinking water for most of the analytes using solid-phase microextraction-gas chromatography-nitrogen-phosphorus detection (SPME-GC-NPD). In contaminated surface water samples, the chromatograms are relatively clean and most of the compounds can be detected at levels lower than 0.5 microgram/l.


Sujet(s)
Chromatographie en phase gazeuse/méthodes , Résidus de pesticides/composition chimique , Pesticides/composition chimique , Pollution chimique de l'eau/analyse , Alimentation en eau/analyse , Calibrage , Modèles linéaires , Concentration osmolaire , Résidus de pesticides/analyse , Pesticides/analyse , Pesticides/classification , Sensibilité et spécificité , Facteurs temps , Alimentation en eau/normes
11.
Ann Oncol ; 8 Suppl 1: 49-52, 1997.
Article de Anglais | MEDLINE | ID: mdl-9187429

RÉSUMÉ

BACKGROUND: The International Prognostic Index (IPI) is widely used to predict outcome of patients with aggressive lymphomas. Our goal was to assess the prognostic value of this index for low-grade lymphoma. PATIENTS AND METHODS: One hundred eighty-two patients with disseminated (stage III or IV) low-grade lymphoma were enrolled in a prospective multicenter trial. According to the initial features, treatment either was started immediately or was deferred until indicated by disease progression. Patients received the same polychemotherapy regimen, given monthly for six cycles. They were assigned to one of four risk groups according to the number of presenting risk factors: low-risk (0 or 1), low-intermediate-risk (2), high-intermediate-risk (3), high-risk groups (4). RESULTS: Survival curves (Kaplan-Meier method) demonstrated a high significant difference for the four groups (log-rank: P < 0.0001). Median survival for the low-risk group has yet to be reached, while that for the three other groups are, respectively, 65, 34, and 12 months. CONCLUSIONS: In this study, the IPI has been found to be an important prognostic tool in low-grade lymphoma and may be used in the selection of appropriate therapeutic approaches for individual patients.


Sujet(s)
Lymphome malin non hodgkinien/mortalité , Lymphome malin non hodgkinien/anatomopathologie , Indice de gravité de la maladie , Humains , L-Lactate dehydrogenase/sang , Lymphome malin non hodgkinien/thérapie , Adulte d'âge moyen , Stadification tumorale , Valeur prédictive des tests , Pronostic , Études prospectives , Analyse de survie , Résultat thérapeutique
13.
Bull Cancer ; 77(8): 811-20, 1990.
Article de Français | MEDLINE | ID: mdl-2207370

RÉSUMÉ

We report a prospective study concerning the association of surgery-chemotherapy and radiotherapy in the treatment of primary high grade digestive non-Hodgkin's lymphomas in 19 patients. The analysis of 11 stages IE, 5 stages II1E and 3 stages II2E allowed us to evaluate the efficacy and the tolerance of this triple therapeutic association. Fifteen patients are alive and well with a median follow-up of 54 months. One of these patients relapsed, but after autologous bone marrow transplantation is in second unmaintained complete remission. Four patients died of intercurrent aetiology although one death was related to treatment morbidity. Our results and the analysis of literature data lead us to recommend the triple association in the treatment of stage II2E high grade primary digestive lymphomas (PDL) and for PDL without complete resection. However, surgery and chemotherapy appear to be sufficient in the treatment of stages IE and II1E with complete resection.


Sujet(s)
Association thérapeutique , Tumeurs de l'appareil digestif/thérapie , Lymphome malin non hodgkinien/thérapie , Adulte , Sujet âgé , Protocoles de polychimiothérapie antinéoplasique/usage thérapeutique , Transplantation de moelle osseuse , Tumeurs de l'appareil digestif/anatomopathologie , Femelle , Humains , Lymphome malin non hodgkinien/anatomopathologie , Mâle , Adulte d'âge moyen , Stadification tumorale , Pronostic , Études prospectives
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE